한국여성에서 자간전증과 peroxisome proliferator-activated receptor-γ, methylenetetrahydrofolate reductase 유전자 다형성의 연관성

키워드

참고문헌 (39)

1. Dekker GA, "Etiology and pathogenesis of preeclampsia:current concepts", 179, pp.1359~1375 (1998)
2. Sundvold H, "Identification of a novel peroxisome proliferator-activated receptor(PPAR)gamma promoter in man and transactivation by the nuclear receptor RORalpha1", 287, pp.383~390 (2001)
3. Hay W, "Placental transport of nutrients to the fetus", 42, pp.215~22 (1994)
4. Barak Y, "PPAR gamma is required for placental,cardiac,and adipose tissue development", 4, pp.585~595 (1999)
5. Joffe GM, "The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group", 179, pp.1032~1037 (1998)
6. McCully KS, "Homocysteine and vascular disease", 4, pp.386~389 (1996)
7. Brattstrom LE, "Moderate homocysteinemia- a possible risk factor for arteriosclerotic cerebrovascular disease", 15, pp.1012~6 (1984)
8. Powers RW, "Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation", 179, pp.1605~1611 (1998)
9. Hansen DK, "Alterations in folate metabolism as a possible mechanism of embryotoxicity", pp.407~431 (1997), Berlin: Springer
10. Powers RW, "Methylenetetrahydrofolate reductase polymorphism,folate,and susceptibility to preeclampsia", 6, pp.74~79 (1999)
11. Grandone E, "Factor V Leiden,C>T MTHFR polymorphism and genetic susceptibility to preeclampsia", 77, pp.1052~1054 (1997)
12. Sohda S, "Methylenetetrahydrofolate reductase polymorphism and preeclampsia", 34, pp.525~526 (1997)
13. Rady PL, "Genetic polymorphism of methylenetetrahydrofolate reductase(MTHFR) and methionine synthase reductase(MTRR) in ethnic population in texas; A report of a novel MTHFR polymorphic site, G1703A", 107, pp.162~168 (2002)
14. 윤은혜, "임신성 고혈압 한국인 환자에서 C677T Methylenetetrahydrofolate reductase 유전자 변이, 호모시스테인, 지질성분의 감수성 연구", Obstetrics & Gynecology Science, 44(11), pp.2010~2015 (2001), 대한산부인과학회
15. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, "Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy", 183, pp.1~22 (2000)
16. Schoonjans K, "The peroxisome proliferator activated receptors(PPARS)and their effects on lipid metabolism and adipocyte differentiation", 1302, pp.93~109 (1996)
17. Desvergne B, "Peroxisome proliferator- activated receptors:nuclear control of metabolism", 20, pp.649~688 (1999)
18. Spiegelman BM, "PPAR-gamma:Adipogenic regulator and thiazolidinedione receptor", 47, pp.507~514 (1998)
19. Davidson MB, "Clinical implications of insulin resistance syndromes", 99, pp.420~426 (1995)
20. Hubel CA, "Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours postpartum", 174, pp.649~982 (1996)
21. Sattar N, "Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction", 84, pp.128~130 (1999)
22. Stumvoll M, "The peroxisome proliferator-activated receptor gamma2 pro12ala polymorphism", 51, pp.2341~2347 (2002)
23. Deeb SS, "A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity,lower body mass index and improved insulin sensitivity", 20, pp.284~287 (1998)
24. Poulsen P, "Impact of two common polymorphisms in the PPArgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic tweens: thrifty genotype, thrifty phenotype, or both?", 52(type type), pp.194~198 (2003)
25. Gonzalez Sanchez JL, "Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity,insulin sensitivity and lipid profile in the Spanish population", 147, pp.495~501 (2002)
26. Rosmond R, "The Pro12ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men", 19, pp.159~163 (2003)
27. stgren CJ, "Peroxisome proliferator- activated receptor-gamma Pro12Ala polymorphism and the association with blood pressure in type 2 diabetes : Skaraborg Hypertension and Diabetes project", 21, pp.1657~1662 (2003)
28. Laasanen J, "Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with preeclampsia", 69, pp.77~82 (2002)
29. Mori H, "The Pro12Ala substitution in PPARgamma is associated with resistance to development of diabetes in the general population:possible involvement in impairment of insulin secretion in individuals with type 2 diabetes", 50, pp.891~894 (2001)
30. Moon MK, "Genetic polymorphismsin peroxisome proliferator activated receptor γ are associated with Type 2 diabetes mellitus and obesity in the Korean population", 22, pp.1161~1166 (2005)
31. Wang XL, "Peroxisome proliferator-activated receptor gamma C161T polymorphism and coronary artery disease", 44, pp.588~594 (1999)
32. Knoblauch H, "Peroxisome proliferator-activated receptor gamma gene locus is related to body mass index and lipid values in healthy nonobese subjects", 19, pp.2940~2644 (1999)
33. Meirhaeghe A, "A genetic polymorphism of the peroxisome proliferator- activated receptor gamma gene influences plasma leptin levels in obese humans", 7, pp.435~440 (1998)
34. Jacques PF, "Relation between folate status,a common mutation in methylenetetrahydrofolate reductase,and plasma homocysteine concentrations", 93, pp.7~9 (1996)
35. 김영주, "임신성 고혈압 환자에서 C677T Methylenetetrahydrofolate reductase의 유전자적 변이에 관한 연구", 43, pp.1569~1573 (2000)
36. Pepe G, "Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10- methylenetetrahydrofolate reductase", 63, pp.917~920 (1998)
37. Lachmeijer AMA, "Mutations in the gene for methylenetetrahydrofolate reductase,homocysteine levels,and vitamin status in women with a history of preeclampsia", 184, pp.394~402 (2001)
38. Van der Put NM, "A second common mutation in the methylenetetrahydrofolate reductase gene:an additional risk factor for neural-tube defects", 62, pp.1044~1051 (1998)
39. O′Leary VB, "Screening for new MTHFR polymorphisms and NTD risk", 138, pp.99~106 (2005)

관련 논문AI추천